| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |